Results 101 to 110 of about 2,405 (150)
Some of the next articles are maybe not open access.
Nephron, 2008
Triamterene (TA) is a mild ‘potassium-sparing’ diuretic usually employed in combination with other more potent diuretics in the treatment of hypertension. TA pharmacokinetics and pharmacodynamics in normal volunteers, elderly subjects and in patients with renal and hepatic dysfunction are reviewed.
D A, Sica, T W, Gehr
openaire +2 more sources
Triamterene (TA) is a mild ‘potassium-sparing’ diuretic usually employed in combination with other more potent diuretics in the treatment of hypertension. TA pharmacokinetics and pharmacodynamics in normal volunteers, elderly subjects and in patients with renal and hepatic dysfunction are reviewed.
D A, Sica, T W, Gehr
openaire +2 more sources
Journal of Urology, 1985
Triamterene therapy is an unusual cause of nephrolithiasis and, when this agent is found in a stone, generally it is deposited in minor amounts. We report a renal calculus consisting mostly of triamterene and its 2 major metabolites in a patient taking a triamterene-containing drug, and discuss some implications.
E S, Dickstein, W D, Loeser
openaire +2 more sources
Triamterene therapy is an unusual cause of nephrolithiasis and, when this agent is found in a stone, generally it is deposited in minor amounts. We report a renal calculus consisting mostly of triamterene and its 2 major metabolites in a patient taking a triamterene-containing drug, and discuss some implications.
E S, Dickstein, W D, Loeser
openaire +2 more sources
Military Medicine, 1989
A 59-year-old white male presented with a triamterene renal stone and pyelonephritis, requiring percutaneous lithotomy. A combination of hydrochlorothiazide and triamterene had been previously prescribed despite no history of hypokalemia. The indications for potassium replacement therapy and risks of triamterene nephrolithiasis are reviewed.
D P, Dooley, M E, Callsen, J A, Geiling
openaire +2 more sources
A 59-year-old white male presented with a triamterene renal stone and pyelonephritis, requiring percutaneous lithotomy. A combination of hydrochlorothiazide and triamterene had been previously prescribed despite no history of hypokalemia. The indications for potassium replacement therapy and risks of triamterene nephrolithiasis are reviewed.
D P, Dooley, M E, Callsen, J A, Geiling
openaire +2 more sources
Drug and Therapeutics Bulletin, 1964
Triamterene (2, 4, 7-triamino-6-phenyl pteridine, Dytac - SKF) is a new oral diuretic. It increases the urinary excretion of sodium, chloride and bicarbonate, but decreases the urinary loss of potassium. The diuretic effect of triamterene depends neither on carbonic anhydrase nor on antagonism of aldosterone, but appears to be due to a direct action of
openaire +1 more source
Triamterene (2, 4, 7-triamino-6-phenyl pteridine, Dytac - SKF) is a new oral diuretic. It increases the urinary excretion of sodium, chloride and bicarbonate, but decreases the urinary loss of potassium. The diuretic effect of triamterene depends neither on carbonic anhydrase nor on antagonism of aldosterone, but appears to be due to a direct action of
openaire +1 more source
Metabolic Fate and Solubility of Triamterene—Not an Explanation for Triamterene Nephrolithiasis
Journal of Pharmaceutical Sciences, 1986In an attempt to explain the triamterene stone diathesis, we studied the excretion and solubility of triamterene, 1, and its metabolite, the sulfate ester of the hydroxy derivative of triamterene, 3. The urinary excretion pattern and metabolism in stone formers was the same as in other chronic users of triamterene or healthy volunteers.
F, Sörgel, B, Ettinger, L Z, Benet
openaire +2 more sources
Excretion of Triamterene and Its Metabolite in Triamterene Stone Patients
The Journal of Clinical Pharmacology, 1985As triamterene users may form kidney stones containing deposits of triamterene and its metabolites, we studied urinary excretion to detect any altered metabolism of triamterene in these patients. We found no significant differences between patients and matched control subjects in total recovery, hourly excretion patterns, and concentrations of ...
openaire +2 more sources
Journal of Urology, 1982
AbstractThe frequency of hospitalization for renal stones was similar for recipients of triamterene, hydrochlorothiazide (alone), thyroid and diazepam among members of a large prepaid health maintenance organization. In 4 triamterene recipients in whom analysis of the stone was done no triamterene was found.
H, Jick, B J, Dinan, J R, Hunter
openaire +2 more sources
AbstractThe frequency of hospitalization for renal stones was similar for recipients of triamterene, hydrochlorothiazide (alone), thyroid and diazepam among members of a large prepaid health maintenance organization. In 4 triamterene recipients in whom analysis of the stone was done no triamterene was found.
H, Jick, B J, Dinan, J R, Hunter
openaire +2 more sources